Please turn JavaScript on
header-image

Pharmaceutical Business review

Want to stay in touch with the latest updates from Pharmaceutical Business review? That's easy! Just subscribe clicking the Follow button below, choose topics or keywords for filtering if you want to, and we send the news to your inbox, to your phone via push notifications or we put them on your personal page here on follow.it.

Reading your RSS feed has never been easier!

Website title: Pharmaceutical Business review

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  1.35 / day

Message History

Ecnoglutide is a cyclic adenosine monophosphate (cAMP)-biased glucagon-like peptide-1 (GLP-1) receptor agonist intended for chronic weight management in Chinese adults with obesity or who are overweight.

It is distinguished by its selective activation of the cAMP signalling pathway, reducing β-arrestin recruitment. This mechanism enables potent and sustained weight los...


Read full story

This marks the first FDA approval of a TYK2 inhibitor specifically for this indication.

The regulator granted this approval following findings from the pivotal POETYK PsA-I and POETYK PsA-II Phase III studies, which assessed the safety and efficacy of once-daily 6mg Sotyktu in adults with active PsA.

Both trials showed notable improvements in disease activity, w...


Read full story

This approval applies to patients who have undergone at least one prior treatment, including a proteasome inhibitor and an immunomodulatory agent.

It aims to provide a new standard of care (SOC) and address disease relapse, which affects approximately 40% of patients.

This approval was supported by data from the ongoing Phase III MajesTEC-3 study, which com...


Read full story

The licences sourced from Carisma Therapeutics and the University of Pennsylvania include methods and constructs specifically engineered for function within these immune cell populations.

The designs complement Liberate Bio’s lipid nanoparticle (LNP) delivery platform, which enables the selective programming of macrophages and monocytes in vivo.

With both t...


Read full story

CordenPharma Colorado will occupy the entire premises under a 15-year lease.

The new LEED Gold-certified facility has flexible laboratory configurations, advanced mechanical and utility systems, and waste management to facilitate intricate scientific activities.

Conveniently situated next to CordenPharma Colorado’s peptide manufacturing site, this location will ...


Read full story